Research
The MORC2 gene plays a fundamental role in regulating how DNA is utilized within the cell. This central function means that discoveries about MORC2 have implications beyond M2RD itself. Research on MORC2 is providing broader insights into genetics, protein function, and cellular biology, including its roles in metabolism, nerve development, and immune system activity in both affected individuals and the general population.
MORC2-Related Disorder (M2RD), also known as CMT2Z, DIGFAN, SMA-like disorder, and Cockayne-like syndrome, is a rare genetic condition caused by mutations in the MORC2 gene. Because M2RD was only recently recognized, much remains unknown about how these mutations lead to the neurological, metabolic, immunologic and other severe symptoms that affect patients’ daily lives.
MORCure plays a critical role in advancing scientific discovery by identifying and funding research that will transform how M2RD is understood and, ultimately, how it can be treated. As with any exploration of an emerging disease, progress begins with understanding the fundamentals. In the case of M2RD, this means determining how mutations in MORC2 alter cellular function at the level of DNA. By identifying how MORC2 mutations disrupt normal biological processes, researchers can begin to develop strategies to correct or mitigate these effects in patients.
Although M2RD is considered rare, diagnoses are increasing as access to whole-genome and whole-exome sequencing expands. Because the disorder was first described in 1994 [1], our understanding of how MORC2 mutations drive symptoms remains incomplete and new diagnoses of M2RD patients with symptoms that have not been previously described continues to be reported.
MORCure is committed to supporting research that clarifies how MORC2 impacts other genes and cellular pathways, why disease severity varies among patients and whether existing therapies might offer safe and effective ways to improve patients’ quality of life. Advances in genetic science are occurring at an unprecedented pace, and each discovery brings new insight and new hope for patients and families.
Our research collaboration with the Modis Laboratory at the University of Cambridge represents an important first step toward achieving these goals. Through this work, we aim to:
Focus on MORC2-Related Disorder, a condition representing a significant unmet medical need in the UK and globally.
Identify the molecular mechanisms that drive M2RD.
Explore innovative approaches to treatment, clinical management, and disease classification.
Incorporate patient and caregiver perspectives into the research process.
Promote interdisciplinary and cross-sector collaboration to advance understanding, treatment, and future research strategies for M2RD.
By supporting this work, donors and partners are helping to illuminate a disease that has long remained hidden while also advancing core scientific knowledge on gene function that will benefit the human race. Every discovery brings us closer to hope.
References
Frith, J. A., McLeod, J. G., Nicholson, G. A., & Yang, F. (1994). Peroneal muscular atrophy with pyramidal tract features (hereditary motor and sensory neuropathy type V): A clinical, neurophysiological, and pathological study of a large kindred. Journal of Neurology, Neurosurgery & Psychiatry, 57(11), 1343–1346